dr. motzer on first-line treatment of metastatic rcc
Published 4 years ago • 525 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
-
3:36
first-line treatment of poor-risk metastatic renal cell carcinoma
-
1:11
dr. motzer on the milestone of immunotherapy in rcc
-
2:25
dr. motzer on a phase ii trial of nivolumab for mrcc
-
4:25
first-line therapy for renal cell carcinoma
-
5:50
first-line considerations in metastatic renal cell carcinoma
-
8:43
optimizing the upfront treatment of metastatic renal cell carcinoma
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
5:36
sequencing metastatic renal cell carcinoma treatments
-
12:07
evidence in first-line metastatic renal cell carcinoma
-
1:24
dr. motzer on the tivo-1 trial with tivozanib in advanced rcc
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
2:32
dr. motzer on sunitinib versus pazopanib in renal cell carcinoma
-
1:56
dr. robert motzer reviews the phase iii comparz study
-
1:28
dr. motzer on the tivo-3 trial examining tivozanib in advanced rcc
-
1:25
dr. motzer discusses nivolumab for mrcc
-
10:40
dr robert motzer, genitourinary oncol service, memorial sloan-kettering cancer center, new york/usa
-
2:16
dr. robert motzer analyzes overall survival in the tivo-1 study
-
1:25
dr. tannir on the combination of sunitinib and temsirolimus for metastatic renal cell carcinoma